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Abstract.  We have examined the fate of newly synthe- 
sized T  cell antigen receptor (TCR) subunits in a  T 
cell hybridoma deficient in expression of the clono- 
typic 13 chain. Synthesis and assembly of the remain- 
ing chains proceed normally but surface expression of 
TCR chains is undetectable in these cells. A  variety of 
biochemical and morphological techniques has been 
used to show that the TCR chains in these cells fail to 
be transported to any of the Golgi cisternae. Instead, 
they are retained in a pre-Golgi compartment which is 
either part of or closely related to the endoplasmic 
reticulum. The CD3-6  chain is degraded by a  non- 
lysosomal process that is inhibited at temperatures at 
or below 27°C.  By contrast, the remaining chains 
(CD3-e, CD3-'t, and ~) are very stable over 7 h. We 
propose possible mechanisms that may explain the dif- 
ferential fate of TCR chains retained in a pre-Golgi 
compartment. 
T 
hE study of multicomponent protein complexes can 
address may questions concerning the assembly, intra- 
cellular transport, and eventual fate of individual pro- 
tein subunits.  In this respect,  the T  cell antigen receptor 
(TCR) ~ is  an  excellent model  for  examining how  a  cell 
stoichiometrically assembles a multimeric protein complex 
and ensures that only complete receptor molecules are ex- 
pressed on the cell surface. Both the mature human and mu- 
rine T cell antigen receptors function to recognize foreign 
antigens via a clonotypic disulfide-linked heterodimer com- 
posed of an acidic Ti-a and a basic Ti-13 chain (reviewed by 
Marrack and Kappler, 1986). Noncovalently associated with 
the Ti-ctl3 dimer are a group of three structurally similar pro- 
teins (8,  ~,  y) termed the CD3  complex and a  disulfide- 
linked homodimer ~  (Borst et al.,  1983;  Kanellopoulos et 
al.,  1983;  Samelson et al.,  1985a;  Oettgen et al.,  1986). 
Several studies in both the human and murine systems have 
shown the importance of concomitant expression of both 
Ti-a and Ti-13 with the CD3 chains and ~  for cell surface 
expression  of the  TCR.  In  T  cell  mutants  lacking  Ti-a 
(Schmitt-Verhulst  et al.,  1987; Saito  et al.,  1987a),  Ti-~ 
(Weiss and Stobo, 1984; Sussman et al., 1988b), or ~ (Suss- 
man et al., 1988a),  marked reduction in surface expression 
of the remaining TCR chains occurs. Transfecting the genes 
for Ti-ct or Ti-13 into mutant cells deficient in the synthesis 
of these chains can restore surface expression of functional 
TCRs in these cells (Ohashi et al., 1985; Saito et al., 1987b). 
T cell precursors isolated from fetal thymus or leukemic cells 
1. Abbreviations used in this paper: DOM, l-deoxymanojirimycin;  Endo D, 
endo-13-N-acetylglucosaminidase D; Endo H, endo-13-N-acetylglucosamini- 
dase  H;  ER,  endoplasmic reticulum;  MME,  methionine methyl  ester; 
NEPHGE, nonequilibrium pH gradient electrophoresis;  TCR, T cell anti- 
gen receptor;  TRAE T cell receptor-associated  protein. 
corresponding to the earliest stages  of intrathymic T  cell 
maturation transcribe mRNAs for the 13 and CD3 chains but 
not for the a  chain (Furley  et al., 1986; Van Dongen et al., 
1987; Samelson et al., 1985b; Raulet et al., 1985; Snodgrass 
et al., 1985). TCR chains other than the a chain are synthe- 
sized in these cells but fail to be transported to the plasma 
membrane (Hannum et al., 1987; Furley et al., 1986;  Farr 
et al., 1985). Subsequently, a  chains are expressed. This al- 
lows the formation of the Ti-al3 heterodimer which, in turn, 
allows the full TCR to appear on the cell surface (Furley et 
al.,  1986; Van Dongen et al.,  1987).  All of these observa- 
tions suggest that delivery of TCR complexes to the cell sur- 
face requires the synthesis of all of the receptor chains. 
Studies carried out in our laboratory with the murine T 
cell hybridoma line, 2B4, identified one possible mechanism 
by which T cells prevent the surface expression of incom- 
pletely assembled receptor complexes. These studies showed 
that  TCR  chains  are  not  synthesized  in  stoichiometric 
amounts (Minami et al., 1987).  Rather, five of the receptor 
chains (Ti-a, Ti-13, CD3-6, CD3-e, CD3-y) are synthesized 
in great excess (70-90%) over the amount that is eventually 
assembled on the cell surface. The ~ chain is synthesized in 
limiting amounts and therefore may determine the number 
of seven-member receptors made. While complete receptors 
are transported to the cell surface, partial complexes are not. 
Instead, they are degraded intracellularly, mostly in lyso- 
somes. Consistent with the biosynthetic studies in 2B4 cells 
are more recent observations made in variant T cells lacking 
expression of the ~ chain. In such cells, partial, five-member 
complexes were found to be routed to lysosomes where they 
were rapidly degraded (Sussman et al.,  1988a). 
In the present study, we provide evidence for the existence 
of an additional mechanism that causes retention of abnor- 
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that newly synthesized TCR chains in a T cell hybridoma 
variant that fails to synthesize any Ti-13 chains are assembled 
into partial complexes in the endoplasmic reticulum (ER) but 
fail to be transported to the Golgi system. Surprisingly, the 
fate of the individual chains within the ER varied. Whereas 
CD3-6, CD3-y, and ~ all remained stably trapped within the 
ER, CD3-$ underwent rapid degradation.  The degradation 
was not inhibited by several inhibitors of lysosomal function 
but was inhibited by lowering the temperature to 27°C. We 
postulate several mechanisms that may explain the differen- 
tial fate of TCR chains retained in a pre-Golgi compartment. 
Materials and Methods 
Reagents 
1-Deoxymanojirimycin  (DOM)  and  endo-l~-N-acetylglucosaminidase  H 
(Endo H), were purchased from Genzyme (Boston, MA). Endo-I~-N-acetyl- 
glucosaminidase D (Endo D) was supplied by Calbiochem-Behring Corp. 
(La Jolla, CA). Pharmacological agents were obtained from the following 
sources: ammonium chloride from Aldrich (Milwaukee, WI); methionine 
methyl ester, chloroquine, and monensin from Sigma Chemical Co.  (St. 
Louis, MO); and leupeptin from Boehringer Mannheim Biochemicals (In- 
dianapolis, IN). 
Cells 
The murine T cell hybridoma 2B4 is a cell line generated by fusion of pigeon 
cytochrome c-primed lymph node cells to the BW5147 thymoma cell line 
(Hedrick et al.,  1982). As a consequence, these hybridoma cells produce 
mRNAs for four clonotypic chains, 2B4-et, BW5147-ct, 2B4-B, and BW5147- 
13 (Sussman et al.,  1988b). The subclone 2B4.11, derived by limiting dilu- 
tion (Ashwell et al., 1987), was used in these studies. The [I-deficient T cell 
line 21.2.2 was derived by repetitive subcloning of 2114.11 cells (Sussman 
et al.,  1988b) and was kindly provided by Dr. J. Ashwell (National Cancer 
Institute). Northern blot analyses have revealed that 21.2.2 cells fail to ex- 
press mRNAS for 2B4-1], BW5147-1~, and 2B4-a, but do express mRNA for 
BW5147-ct (Sussman et al., 1988b). The Chinese hamster ovary (CHO) mu- 
tant cell line, LECI (Stanley et al., 1975), was obtained from the American 
Type  Culture  Collection  (Roekville,  MD).  All  cells  were  cultured  in 
medium as described previously (Samelson and Schwartz,  1984). 
Antibodies 
The following antibodies were used to precipitate the TCR chains: anti-e, 
145-2C11 (2C11), monoclonal hamster IgG that binds to the murine e chain 
(Leo et al.,  1987); anti-8, attinity-pudfied anti-peptide antisera raised in a 
goat immunized  with a  COOH-terminal  peptide of the murine 8  chain 
(Samelson et al.,  1986b); anti-y, No.  125, polyclonal antisera raised in a 
rabbit immunized with purified y and e chains; anti-~ No.  124, polyclonal 
antisera raised in a rabbit immunized with purified murine ~ chain. This 
anti-~ serum causes dissociation of ~ from the rest of the complex (Weiss- 
man et at.,  1986).  For immunoprecipitation, anti-e, -3, and -~ antibodies 
were bound to protein A-agarose (Bethesda Research Laboratories, Gaith- 
ersburg, MD). Anti-8 was covalently coupled to CNBr-activated Sepharose 
beads (Pharmacia Fine Chemicals, Uppsala, Sweden). To precipitate trans- 
ferrin receptor, human transferrin (iron saturated; Miles Scientific, Naper- 
ville,  IL) was covalenfly coupled to CNBr-activated Sepharose beads as 
above and was kindly supplied by Dr. J. Harford (National Institute of Child 
Health  and  Human  Development).  The  monoclonal  hamster  antibody, 
500A2, binds to the murine e chain and was a generous gift from Dr. J. Alli- 
son (University of California at Berkeley). Peroxidase-conjugated, affinity- 
purified, goat anti-hamster IgG was purchased from Kirkegaard &  Perry 
Laboratories,  Inc.  (Gaithersburg, MD). 
Radioiodination, Metabolic Labeling, 
lmmunoprecipitation, and Electrophoresis 
Lactoperoxidase-catalyzed radioiodination and electrophoretic analysis of 
samples were performed as previously described (Samelson et al.,  1985a, 
1986a).  Cells  were  metabolically  labeled  with  [35S]methionine or  3H- 
leucine as follows.  [ass]methionine: Cells were preincuhated for 10 min at 
37"C in methionine-free RPMI  1640 medium (Biofluids Inc., Roekville, 
MD) containing 5 %  FBS and labeled for 5-30 rain at 1  x  107 cells/ml 
with 0.25  mCilml [35S]methionine (Tmn-35S-label; ICN Radiochemicals, 
Irvine, CA).  3H-leucine:  Cells were preincubated for 10 min at 37"C in 
leucine-free RPMI 1640 (Biofluids Inc.) and labeled for 15 min at 5  x  107 
cells/ml  with  5  mCi/ml  3H-leucine (ICN  Radioehemicals).  When  indi- 
cated,  labeled cells were chased with complete medium at the specified 
temperatures. Solubilization and immunoprecipitation were performed as pre- 
viously described (Samelson et al.,  1985a) except anti-8 and anti-y im- 
munoprecipitates were washed in 0.1%  SDS and 0.2%  SDS/0.2%  sodium 
deoxycholate,  respectively.  To  quantitate  radioactivity  incorporated  into 
protein, band intensities on autoradiograms were determined by scanning 
densitometry using a Hoefer densitometer and computer analyzed using the 
Appligration  II  data  analysis  program  (Dynamics  Solutions,  Pasadena, 
CA). 
Endoglycosidase Treatments 
Digestion with Endo H was performed by incubating immunoprecipitated 
proteins for 16 h at 37°C with 5 mU Endo H in 50 Ixl of 0.1 M sodium phos- 
phate buffer, pH 6.1, containing 0.1% Triton X-100, 0.03% SDS, and 20 mM 
EDTA. Digestion with Endo D was similarly performed with 2.5 mU Endo 
D in 50 Ixl of 0.02 M sodium phosphate buffer, pH 6.5 containing 0.1% Tri- 
ton X-100,  and 6  mM EDTA. 
Electron Microscopy 
The ultrastructural localization of CD3-e chains was studied in 2B4 and 
21.2.2  cells  by  preembedding,  immunoperoxidase  electron  mic  _rp_s3~o__  ~ 
using the 5(X)A2 antibody. Cells were grown on glass coverslips, fixed in 
formaldehyde, permeabilized, incubated with 500A2 followed by peroxidase- 
conjugated, goat anti-hamster IgG, reacted with diaminobenzidine hydro- 
chloride/H202, and prepared for electron microscopy as described by Yuan 
et al.,  1987. 
Results 
A E-Deficient T Cell Hybridoma Variant Fails 
To Express T Cell Receptor on the Cell Surface 
The T  cell  antigen receptor is a macromolecular complex 
composed  of  at  least  seven  transmembrane  chains.  The 
clonotypic a  and 1~ glycoproteins exist as a disulfide-linked 
heterodimer  and  are  noncovalently  associated  with  a 
disulfide-linked  homodimer,  ~,  and three other invariant 
chains termed the CD3 complex.  The CD3 chains include 
CD3-e and two glycoproteins, CD3-8 and CD3-y.  Surface 
expression of TCR chains was studied in two murine T cell 
hybridomas, 2B4 and 21.2.2.2B4 cells synthesize all seven 
chains of the TCR (Samelson et al., 1985a). 21.2.2 is a vari- 
ant of 2B4 deficient in the expression of 13 chains and was 
derived by repetitive subcloning of 2B4 cells (Sussman et al., 
1988b).  To analyze the expression of TCR on the cell sur- 
face, intact 2B4 and 21.2.2 cells were subjected to lactoper- 
oxidase-catalyzed surface radioiodination, cells were lysed 
in detergent, and the solubilized proteins were immunopre- 
cipitated with an anti-CD3-~ antibody. Samples were ana- 
lyzed  by  two-dimensional  nonreducing/reducing  diagonal 
gels.  Fig.  1 A shows that the anti-e antibody coprecipitates 
the entire TCR complex of 2B4 cells. In contrast, ~deficient 
21.2.2  cells  have a  complete  lack  of any detectable  TCR 
subunits on the cell surface when anti-~ antibodies (Fig.  1 
B) are used for immunoprecipitation. These results can be 
confirmed by fluorescent cell sorter analysis using anti-e an- 
tibodies (data not shown). 
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TCR chains in 2B4 and 21.2.2 T 
cell hybridomas. Intact cells were 
surface  labeled  by  lactoperoxi- 
dase-catalyzed  radioiodination. 
The cells were detergent solubi- 
lized  and  the  lysates were  im- 
munoprecipitated with an anti-e 
antibody. Immunoprecipitated  pro- 
teins  were  analyzed  by two-di- 
mensional nonreducing/reducing 
diagonal  SDS-PAGE on  13% 
gels.  The positions  of the  TCR 
chains in 2B4 cells (A) or 21.2.2 
cells (B) are indicated. The posi- 
tions of M, markers appear to the 
right of each panel; values are in 
10  -3  X  M,. 
Biosynthesis of TCR Chains Is Preserved in 21.2.2 Cells 
To determine whether the 13-deficient ceils were able to syn- 
thesize the other TCR chains,  we studied 21.2.2  and 2134 
cells  by  metabolic  labeling  with  [35S]methionine.  Cells 
were pulse  labeled,  extracted with  Triton X-100,  and  the 
solubilized proteins were immunoprecipitated with either an 
anti-~ antibody or an anti-~ antibody. Samples were analyzed 
by two-dimensional nonequilibrium pH gradient electropho- 
resis (NEPHGE)/SDS-PAGE gels. Fig. 2 A shows the 2B4 
control immunoprecipitation with anti-e where all receptor 
subunits  can be  seen except I~  which  labels  poorly with 
pS]methionine.  In  intentionally  overexposed  autoradio- 
grams, the 13 chain can be seen as a neutral 40-kD protein 
to the left of the ap protein. The precursor (ap) and mature 
(tt,~) forms of the a  subunit can be separated as shown due 
to a change in charge subsequent to the addition of sialic acid 
(Lippincott-Schwartz et al., 1988). The murine T cell recep- 
tor-associated protein (TRAP), a protein that is transiently 
associated with the newly synthesized receptor chains, has 
recently been described by our laboratory (Bonifacino et al., 
1988) and appears on this NEPHGE as two regions of radio- 
activity at 26 kD. TRAP that has completely entered the first 
dimension gel resolves as a very basic protein while the re- 
mainder migrates as a streak beginning at the origin of the 
NEPHGE tube. 
Immunoprecipitation of TCR chains with anti-e antibodies 
from 21.2.2 cells reveals only the CD3 chains (6, e, T) and 
the TRAP protein as  shown in Fig.  2  B.  The absence of 
coprecipitated a  and ~ in 21.2.2 cells can represent either a 
failure to synthesize these chains or a failure to form a stable 
complex between a, ~, and the CD3 complex when 13 is not 
present. That these cells synthesize ~ is confirmed by direct 
immunoprecipitation with anti-~ antibodies (Fig. 2,  C and 
D). Compared to 2B4 cells (Fig. 2 C), 21.2.2 seems to syn- 
Chen et al. Degradation of T Cell Antigen Receptor Chains  2151 Figure 2. Biosynthesis of TCR chains in 2B4 and 21.2.2 cells. 2B4 cells (A and C) or 21.2.2 cells (B and D) were pulse-labeled with 
[35S]methionine for 30 min at 37°C before solubilization and immunoprecipitation with an anti-e antibody (A and B) or an anti-~ antibody 
(C and D). The immunoprecipitated proteins were analyzed by 13 % NEPHGE/SDS-PAGE under reducing conditions. The identity of the 
TCR chains in these gels was established from previous work (Samelson et al., 1985a, 1986a). The positions of 8, E, y, and ~ are indicated. 
The position of TRAP which has completely entered the first-dimension gel is labeled. The remainder migrates as a streak beginning at 
the origin of the NEPHGE tube. ctp and am indicate the precursor and mature forms of the ct chains, respectively. The I~ chains are poorly 
labeled under these conditions and are not apparent in A. The positions of Mr markers are shown to the left of the figure. Values are ex- 
pressed as  10  -3  x  Mr. 
thesize an even greater amount of ~ (D).  The biosynthesis 
of the BW5147-~t chain in 21.2.2 cannot be studied directly 
due to the lack of an appropriate antibody. We cannot detect 
any  coprecipitated  BW5147-a  with  the  CD3  chains  when 
anti-e antibodies are used (Fig. 2 B) but we cannot rule out 
the possibility that the  tt chain is not synthesized in these 
cells although the mRNA is expressed. Our observation is 
in contrast to the recent detection of ~t-CD3 complexes in hu- 
man T cell lines (Alarcon et al.,  1988; Koning et al., 1988). 
From these pulse-labeling studies  of 21.2.2,  we conclude 
that biosynthesis of the CD3  subunits continues in the ab- 
sence of 13 subunit expression and that the lack of surface 
receptor expression is not due to impaired biosynthesis of the 
remaining chains. 
Receptor Subunits Are Not Transported to the 
Medial Golgi System in 21.2.2 Cells 
Further studies were conducted to trace the route followed 
by the receptor chains of 21.2.2 cells after biosynthesis in the 
endoplasmic reticulum.  Since these chains  failed to reach 
their ultimate destination on the plasma membrane, we can 
contrast the intracellular membrane transport of CD3 com- 
ponents  in  21.2.2  with  that  of  2B4.  The  transport  of 
glycosylated receptor subunits through the Golgi system can 
be monitored by following acquisition of resistance to diges- 
tion by Endo H. This enzyme catalyzes the hydrolysis of the 
chitobiose core of high mannose oligosaccharides that exist 
before  reaching  the  medial  Golgi  system  (Tarentino  and 
Maley, 1974).  Once glycoproteins arrive at the medial Golgi, 
N-acetylglucosamine is  added  and the  carbohydrate inter- 
mediates that are generated are no longer sensitive to cleav- 
age by Endo H (Dunphy et al.,  1985; reviewed by Kornfeld 
and Kornfeld,  1985).  We analyzed processing  of glycosy- 
lated CD3 chains in 2B4 and 21.2.2 cells by pulse labeling 
cells with [35S]methionine  and chasing for 1 or 2 h at 37°C. 
TCR subunits were isolated with anti-8 antibodies and anti-y 
antibodies. Half of each immunoprecipitate was treated with 
Endo H, and anti-8 samples were analyzed under nonreduc- 
ing SDS-PAGE gels (Fig. 3). Anti-y samples for 21.2.2 and 
2134 were analyzed under reducing SDS-PAGE gels and two- 
dimensional NEPHGE gels, respectively (data not shown). 
The Endo H-resistant species of CD3-8 and -y in 2B4 and 
21.2.2 cells were quantitated by scanning densitometry ofau- 
toradiograms and shown in Table I. 
The murine CD3-8 chain contains three N-linked carbo- 
hydrate chains, one of which is processed to complex carbo- 
hydrates in the mature 8  chain while two remain in a high 
mannose form (van den Elsen et al., 1985; Chen, C., unpub- 
lished  observations).  The  single  N-linked  carbohydrate 
chain of the murine CD3-y chain is processed to complex 
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CD3-8  occurs in 2B4 cells but not 
in 21.2.2 cells. 2B4 and 21.2.2 cells 
were pulse-labeled  for 15 min at 37°C 
with pSS]methionine  and chased for 
1 or 2 h in complete medium at 37°C. 
Cells were detergent solubilized and 
the 8 chain was immunoprecipitated 
with anti-6  antibodies.  Half of the 
immunoprecipitated  proteins  were 
treated with Endo H and samples were 
analyzed by 13% SDS-PAGE  gels un- 
der nonreducing  conditions. The posi- 
tions of M~ markers are indicated to 
the left of the figure; values are in 
10  -s  x  Mr. P, pulse; lh C,  1 hour 
chase; 2h C, 2 hour chase. 
sugars in the mature glycoprotein (Krissansen et al.,  1987; 
Haser et al.,  1987;  Chen,  C.,  unpublished observations). 
Fig. 3 shows that after a 15-min pulse, all newly synthesized 
26-28-kD 8 precursors are sensitive to cleavage by Endo H 
to a 16-kD species in both cell lines. After a 1-h chase, 55 % 
of the 5 population in 2B4 cells becomes partially resistant 
to Endo H as evidenced by the appearance of a 21-kD species 
(Fig. 3 and Table I). At 2 h, 75 % of the remaining 5 is par- 
tially Endo H resistant in 2B4 cells. In contrast, no detect- 
able Endo H-resistant forms of 8 are seen in 21.2.2 cells over 
a 2-h (or longer) chase period. The 2B4 5 precursor forms 
appear as a nondiscrete band around 26-28-kD, whereas the 
8  precursor in 21.2.2 is a  discrete 26-kD species. Despite 
this, migration of the deglycosylated newly synthesized 8 is 
identical in the two cell lines.  These variable 6  precursor 
forms may reflect different rates of carbohydrate processing 
in the rough endoplasmic reticulum of 2B4 and 21.2.2 cells. 
Table I shows that while 66 % of CD3-y in 2B4 cells acquires 
Endo H resistance over a 2-h chase period, CD3-y in 21.2.2 
does not. These findings imply that in 21.2.2 cells, 5, y, and 
the associated CD3-e chain do not reach the medial Golgi 
Table L Quantitation of  Processed CD3-8 and -y Chains 
to Endo H-resistant Forms in 2B4 and 21.2.2 Cells 
Endo H-resistant (in percent) 
CD3-5  CD3-y 
Chase time 
(in hours)  2B4  21.2.2  2114  21.2.2 
0  2  0  0  0 
1  55  0  ND  0 
2  75  0  66  0 
2B4 and 21.2.2  cells were pulse labeled for 15 min with [sSS]methionine  and 
chased in complete medium for 1 or 2 h at 37°C.  CD3-5  samples were pre- 
pared as described in the legend of Fig. 3. CD3-y chains were immunoprecipi- 
tated with anti-y antibodies and half of the immunoprecipitated proteins was 
treated with Endo H. Anti-y samples from 21.2.2  were analyzed by 13 % SDS- 
PAGE gels under reducing conditions.  2B4 anti-'/samples were resolved by 
NEPHGE/SDS-PAGE  under reducing  conditions.  Quantitation  of Endo H- 
resistant species was performed by scanning densitometry of bands on the auto- 
radiograms. The percent of remaining chains which were Endo H resistant are 
shown for each time point. 
but are blocked in a premedial Golgi compartment. The data 
in Table I also suggest that transport of TCR chains in these 
murine T  cells is not a  slow process as has recently been 
shown by Alarcon et al.  (1988) in human T  cells. We find 
that >50%  of CD3-8  chains are processed in the medial 
Golgi of 2B4 cells after a  1-h chase. 
Of note in Fig. 3 is the relative rapid loss of newly synthe- 
sized 8 chains in both 2B4 and 21.2.2 cells. The disappear- 
ance seen in 2B4 cells over a 2-h chase period can be attrib- 
uted  mostly  to  lysosomal  degradation  of excess  8  after 
passage through the Golgi system (Minami  et al.,  1987). 
Surprisingly, a similar rate of 6 degradation is seen in 21.2.2 
cells. We analyze this degradation of 6 in more detail in later 
figures. 
Receptor Subunits Are Blocked in a Pre-cis-Golgi 
Compariment in 21.2.2 Cells 
To determine whether the CD3-6  and  -Y chains in 21.2.2 
cells accumulate in the cis-Golgi stacks, we analyzed the sen- 
sitivity of  these chains to cleavage by Endo D. Endo D hydro- 
lyzes the di-N-acetylchitobiosyl  linkage of asparagine-linked 
oligosaccharides only when the a-mannose residue that is in 
an a-l,3 linkage to the trisaccharide core is unsubstituted in 
the 2 position (Koide and Muramatsu, 1974). Only glycopro- 
teins that have been processed by the cis-Golgi-associated 
~t-l,2  mannosidase I  to  MansGlcNAc2  oligosaccharide in- 
termediates are Endo D  sensitive. 
Because we were unable to accumulate the transiently pres- 
ent but obligatory Man~GlcNAc2 intermediate of CD3-5 in 
2B4 cells as a positive control, we examined the processing 
of the  transferrin receptor in  LEC1  cells as  our control. 
LEC1 cells are CHO fibroblast cells that are missing the en- 
zyme  N-acetylglucosaminyltransferase  I  (Stanley  et  al., 
1975).  Consequently, all MansGlcNAc2 species in this cell 
line do not undergo processing to complex oligosaccharide 
forms containing N-acetylglucosamine, galactose, and sialic 
acid, and should remain Endo D sensitive. Each chain of the 
transferrin receptor, which is a disulfide-linked homodimer 
comprised of two 90-kD glycoproteins in the hamster and 
two 95-kD glycoproteins in the mouse (Van Agthoven et ai., 
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21.2.2 cells do not accumulate in 
the  cis-Gol~.  (A)  LECI  CHO 
fibroblast cells  and  21.2.2  ceils 
were pulse labeled for 5  min at 
3'7°C  with [35S]methionine and 
chased  for  90  rain  in  complete 
medium at  37°C. Transferdn re- 
ceptor was precipitated from deter- 
gent-sohib'diz~  cell lysates with 
human transferrin coupled to Seph- 
arose. Samples were divided into 
thirds and were either  untreated 
(lanes designated C for control), 
treated with Endo D (lanes desig- 
nated D), or treated with Endo H 
(lanes designated H) before anal- 
ysis by 10% SDS-FAGE gels un- 
der reducing conditions. The posi- 
tions of Mr markers are indicated. 
(B)  21.2.2 cells  were  pulse  la- 
beled  for  10  min  at  37°C with 
[35S]methionine  and  chased  at 
37°C  in  complete  medium  for 
varying times as indicated. CD3-5 
and -y chains were immunopre- 
cipitated  from  detergent-sohibi- 
lized cell lysates with anti-6 and 
anti-y  antibodies,  respectively. 
Half of each sample was treated 
with  Endo  D  and  analyzed  by 
13 % SDS-PAGE gels under non- 
reducing and reducing conditions 
for  anti-8  and  anti-y  samples, 
respectively. The anti-y antibody 
immunoprecipitates  the  8  chain 
in  addition  to the  y  chain  after 
washing  with  0.2%  SDS/0.2% 
deoxycholic acid.  The positions 
of  Mr  markers  are  indicated. 
Values are expressed  as  10  -3  × 
Mr. 
1984; Testa, 1985), has three N-linked carbohydrate chains. 
Two of these chains remain in a high mannose form in the 
mature receptor while one is processed to complex carbohy- 
drates (Newman et al.,  1982). Fig. 4 A shows that in LEC1 
cells,  the  transferrin  receptor is  resistant  to  Endo  D  in  a 
5-min pulse but becomes partially sensitive to Endo D after 
a  90-min chase.  The protein remains Endo H  sensitive at 
both time points, consistent with its failure to be processed 
to complex carbohydrates in these cells. In 21.2.2 cells, the 
mouse transferrin receptor remains Endo D resistant in both 
the pulse and chase time points.  Partial Endo H  resistance 
is acquired after a  90-min chase.  Fig.  4  B  shows that the 
CD3-6 and -y chains in 21.2.2 never become Endo D sensi- 
tive at any time points examined. These studies allow us to 
draw the following conclusions. (a) The TCR CD3-8 and -y 
chains fail to acquire Endo D sensitivity and therefore do not 
accumulate in the cis-Golgi.  This implies that these chains, 
and presumably all the TCR chains of 21.2.2, most likely are 
retained in a pre-Golgi compartment which may or may not 
be the ER. (b) The Golgi system of 21.2.2 cells is intact and 
functional since other glycoproteins, such as the transferrin 
receptor, appear to be transported through the Golgi stacks 
where Endo  H  resistance is acquired in the medial Golgi 
system. 
We sought to further define the carbohydrate content of 
N-linked sugars on CD3-fi in 21.2.2 cells by using the carbo- 
hydrate processing inhibitor 1-deoxymanojirimycin (DOM). 
DOM inhibits the ER mannosidase I and allows Mans_gGlc- 
NAc2  species  to  accumulate  in  cells.  When  21.2.2  cells 
were preincubated in the presence of DOM for 2 h, pulsed 
for 5 min, and chased for 1 h in the presence of DOM, the 
Mans_gGlcNAc2 species of CD3-5 was clearly seen as a 27- 
kD glycoprotein. In the absence of DOM, 8 was able to ma- 
ture to a  slightly smaller glycoprotein of 26 kD which re- 
mained sensitive to Endo H  but resistant to Endo D. From 
these studies, we conclude that the final species offi in 21.2.2 
contains between 6 and 8 mannose residues, consistent with 
its localization in a pre-Golgi compartment. 
Differential Fate of TCR Chains in 21.2.2 Cells 
From data shown in Fig.  3, loss of CD3-5 was seen over a 
2-h chase period in 21.2.2 cells.  This observed loss of im- 
munoprecipitable 6  is not due to secretion into the medium 
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Figure  5. Differential  fate of TCR chains in 21.2.2 cells. 21.2.2 cells 
were pulse labeled for 15 min at 37°C with [3~S]methionine and 
chased for 1, 2, 4, or 7 h at 37°C. Labeled proteins were extracted 
in detergent and TCR chains were immunoprecipitated  with anti-8, 
anti-~/, anti-e, and anti-~ antibodies. Anti-8 and anti-~/samples  were 
analyzed  by 13 % SDS-PAGE gels under reducing  conditions. Anti-e 
and anti-~ samples were resolved by 13% two-dimensional non- 
reducing/reducing  diagonal gels. Receptor chains were quantitated 
by scanning  densitometry  of autoradiograms. 12, ~/; o, ~; =, 4; *, 8. 
nor to failure to solubilize (i.e., no additional/5 was recov- 
ered when cells were extracted in the presence of SDS). To 
ensure that there was no conformational change resulting in 
the apparent loss of/5 due to loss of recognition of the anti-/5 
antibody, we performed pulse-chase studies using cyclohexi- 
mide to arrest new/5 synthesis. At different times after the 
addition of cycloheximide, whole cell lysates were resolved 
by SDS-PAGE and 5 was quantitated by immunoblot analy- 
sis. This experiment demonstrated the identical kinetics for 
/5 loss seen by metabolic pulse-chase experiments (data not 
shown). What then is the fate of the other CD3 chains of 
21.2.2 in this pre-Golgi compartment? To address this ques- 
tion, we pulsed 21.2.2 cells with [35S]methionine and chased 
for various times over 7 h at 37°C. TCR subunits were iso- 
lated with anti-/5, anti-7, anti-e, and anti-~ antibodies. Anti-/5 
and  anti-y  samples  were  analyzed under  reducing  SDS- 
PAGE  gels.  Anti-e and anti-~ samples  were run on two- 
dimensional nonreducing/reducing diagonal gels. Receptor 
chains were quantitated by scanning densitometry of auto- 
radiograms and plotted in Fig. 5.  CD3-8 has a half-life of 
45-60 min in the pre-Golgi compartment as shown in Fig. 5. 
In striking contrast to the fate of/5, the other TCR chains, 
Y, e, and 4, remain extremely stable with half-lives of several 
hours. We detect similar kinetics of 6 degradation and 7 sta- 
bility over a 7-h chase period when these chains are copre- 
cipitated with anti-~ antibodies. Thus, the fates of/5 and 7 
are not dependent on the antibodies used for immunopre- 
cipitation. In addition, when 21.2.2 cells were treated with 
tunicamycin or castanospermine, the resultant lack of proper 
carbohydrate chains on/5 and 7 did not alter the fates of  either 
chain in these cells. 
To address the question of whether 8  loss occurs in the 
same compartment of the ER as the site of synthesis and as- 
sembly of receptor subunits, we examined the fate ofe chains 
in 21.2.2 cells when coprecipitated with anti-8 antibodies. If 
8 degradation occurs in the same compartment as the site of 
assembly, we predict that e could continue to be coprecipi- 
tated by anti-8 antibodies, even at chase time points when 
previously synthesized /5  is undergoing degradation.  This 
prediction assumes that the resulting e-7 complex can re- 
bind newly synthesized 8 chains that are not labeled during 
the chase. If/5 degradation and receptor assembly occur in 
separate compartments within the ER, we would expect/5 
and e to be lost with similar kinetics when immunoprecipi- 
tated with anti-/5 antibodies because the resulting ~-7 com- 
plex would have no access to newly synthesized/5 chains. To 
test this hypothesis, 21.2.2 cells were pulsed with [35S]me- 
thionine and chased for various times over 7 h at 37°C. TCR 
subunits were isolated with anti-/5 antibodies and immuno- 
precipitates were washed in the absence of 0.1% SDS to pre- 
vent dissociation of  assembled CD3 complexes. The samples 
were  run  on  two-dimensional  nonreducing/reducing  di- 
agonal gels followed by quantitation of receptor chains by 
scanning densitometry of autoradiograms (data not shown). 
Pulse-labeled e as well as/5 chains were lost over time with 
half-lives of 45-60 min. These results indicate that after the 
loss of newly synthesized/5 from/5-e-y complexes, the sur- 
viving chains cannot reassemble with subsequently synthe- 
sized/5 chains. 
CD3~ Degradation in 21.2.2 Is Not Inhibited by a 
Variety of  Lysosomal Inhibitors 
Having determined that only the CD3-8 chain in 21.2.2 ceils 
undergoes rapid degradation, we sought to determine to what 
extent, if at all, the pre-Golgi degradation of 8 in these cells 
involved lysosomes. To test this, we conducted pulse-chase 
studies of 8 in 21.2.2 and 2114 cells in the absence and pres- 
ence of several inhibitors of lysosomal function: 50 mM 
NI-hCI,  20 mM methionine methyl ester (MME),  100 IxM 
chloroquine,  100  ~tg/ml leupeptin, and 7  pg/ml monensin 
(Wibo and Poole, 1974; Livesey et al., 1980; Seglen, 1983; 
Rote and Rechsteiner, 1983; Ohkuma and Poole, 1981; Poole 
and Ohkuma,  1981; Reeves et al.,  1981; Tartakoff,  1983; 
Libby and Goldberg,  1978).  Fig. 6 clearly shows the dif- 
ferential effects of NI-hC1 and MME on 8  degradation in 
21.2.2 and 2B4 ceils. NFLC1 is effective in completely in- 
hibiting/5 degradation in 2B4 cells over 2 h while it has no 
effect on/5 degradation in 21.2.2 cells (Fig. 6 A). At 7 h, the 
inhibition of lysosomal degradation by NH4CI in 2B4 ceils 
is not complete but is still significant (40 and 4 % of/5 remain 
in the presence and absence of NI-LCI, respectively). MME 
is equally effective in disrupting lysosomal function in 2B4 
cells but has no significant effect on/5 degradation in 21.2.2 
cells (Fig. 6 B). Fig. 7 shows that other lysosomal inhibitors, 
including chloroquine, monensin, and leupeptin, similarly 
fail to retard the degradation of/5 in 21.2.2  cells. Thus, the 
data suggest that CD3-/5 is indeed undergoing degradation by 
two distinct and different degradative systems in 2B4 and 
21.2.2 cells. CD3-/5 is largely degraded by a lysosomal path- 
way in 2B4 cells but by a  nonlysosomal system in 21.2.2 
cells. From data described in this paper, we propose that this 
novel degradative system in T cells is localized to a pre-Golgi 
compartment. 
Effect of Temperature on Pre-Golgi 
Degradation of  CD3-,5 in 21.2.2 
Many biochemical and cellular processes have been shown 
to  exhibit  characteristic  temperature  dependence  curves. 
With regard to intracellular protein degradation, temperature 
can affect several events in this process, some of which can 
be rate limiting. These include local protein unfolding (Pace, 
1975; Snoke and Neurath, 1950) or other structural changes, 
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Figure 6. Fate of CD3-6 in 2134 and 21.2.2 cells:  differential effect 
of NI-hC1 and MME. (A) 2B4 and 21.2.2 cells  were preincubated 
with no drug (control) or with NI-hC1 (50 raM) for 1 h at 37°C be- 
fore pulse labeling  with l~sS]methionine for 15 min at 37°C. Cells 
were chased in complete medium in the absence (control)  or pres- 
ence of 50 mM NH4CI for 1, 2, 4, or 7 h at 37°C. CD3-/5 was im- 
munoprecipitated  from cell lysates with anti-8 antibodies and sam- 
ples were analyzed by  13%  SDS-PAGE  gels under nonreducing 
conditions.  Receptor chains were quantitated  by scanning densi- 
tometry of autoradiograms.  (B) 2B4 and 21.2.2  cells  were prein- 
cubated with no drug (control)  or with MME (20 raM) for 2 h at 
37°C  before  pulse labeling  with  3H-leucine  for  15 rain at 37°C 
Cells were chased in complete medium in the absence (control)  or 
presence of drug for 1, 2, 4, or 7 h at 37°C. CD3-8 was isolated 
and analyzed as described in A. (.4) o, 2B4 NFLC1; L  21M con- 
trol; O, 21.2.2  NH4CI;  e,  21.2.2  control. (B) [], 2B4 MME; a, 
2B4 control; o, 21.2.2  MME;  e, 21.2.2  control. 
proteolytic cleavage by specific enzymes (Yang et al.,  1977), 
and membrane transport of proteins to the degradative or- 
ganelle (Brahm, 1977). Saraste et al. (1986) have shown that 
the movement of newly synthesized proteins out of the ER 
is blocked by incubating ceils at 16°C. In 2B4 cells, we have 
seen  that  maturation  of TCR chains  and  their  subsequent 
delivery to lysosomes are inhibited when cells are placed at 
16°C (Bonifacino et al.,  1988). 
To test the temperature  dependence of pre-Golgi CD3-6 
degradation in 21.2.2 ceils, we pulsed cells with [35S]methi- 
onine and chased for various times over 7 h at five different 
temperatures:  37, 34,  30, 27, and 20°C. Cells were lysed, 8 
subunits were isolated with anti-6 antibodies,  and the sam- 
Figure  7,  Lysosomal inhibitors  do not affect the  fate  of CD3-5 
chains in 21.2.2 cells.  (A) 21.2.2 cells  were preincubated  with no 
drug (control)  or with the following lysosomal inhibitors  at 37°C 
for 1 h: leupeptin  (100 I.tg/ml), chloroquine (100 ~tM), and monen- 
sin (7  p.g/ml). Cells  were pulse labeled  for 15 min at 37°C with 
[35S]methionine and chased in complete medium in the absence 
(control)  or presence of drug for l, 2, 4, or 7 h at 37°C. CD3-5 
was isolated  and analyzed as described in the legend to Fig.  6 A. 
(B) Scanning  densitometry of the autoradiograms  shown in A. o, 
leupeptin;  i,  chloroquine; n, control; o, monensin. 
pies were run on nonreducing SDS-PAGE gels. The CD3-5 
chain was quantitated by scanning densitometry ofautoradio- 
grams and plotted in Fig.  8. The 37°C control curve shows 
the exponential degradation of 6  with a half-life of 60 min, 
consistent with previous experiments.  Lowering the temper- 
ature by 3°C to 34°C increased the half-life of 6 to 100 min. 
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Figure 8. Effect of temperature on nonlysosomal CD3-6 degrada- 
tion in 21.2.2 ceils. 21.2.2 cells were pulse labeled for 15 min at 
37°C with [3SS]metluonine  and chased for 1, 2, 4, or 7 h at the in- 
dicated temperatures. CD3-8 was isolated and analyzed as de- 
scribed in the legend to Fig. 6 A. n, 20°C; m, 27°C; o, 30°C; o, 
34°C; m, 37°C. 
Cells incubated at 30°C exhibited dramatic stabilization of 
6 to degradation (half-life =  190 min) while at temperatures 
of 27°C or lower,  the degradation of 8 was completely in- 
hibited. Thus, the nonlysosomal, pre-Golgi degradation ob- 
served in 21.2.2 cells is completely inhibited at temperatures 
that do not block ER-Golgi transport. An explanation for the 
extreme temperature sensitivity of pre-Golgi degradation in 
these cells requires further characterization. 
Localization of CD3-e in 2B4 and 
21.2.2 Cells by Electron Microscopy 
The ultrastructural distribution of CD3-e chains was exam- 
ined in 2B4 and 21.2.2 cells by immunoperoxidase electron 
microscopy (Fig. 9). We chose to examine the steady-state 
levels of CD3-e rather than CD3-8 because of the stability 
of intracellular e in 21.2.2 cells and the availability of  a useful 
anti-e antibody. Cells were permeabilized with saponin and 
incubated with 500A2, an anti-e monoclonal antibody. Fig. 9 
A shows HRP staining of 2B4 ceils in several structures in- 
cluding  ER cisternae,  nuclear envelope,  Golgi cisternae, 
lysosomes, and plasma membrane. No staining of mitochon- 
dria and cytoplasm is observed. The morphological data are 
consistent with the biochemical evidence for movement of 
TCR complexes containing CD3-e out of the ER to the Golgi 
complex  in  2B4  cells.  Incomplete  complexes  containing 
CD3-e are delivered to lysosomes, which are clearly stained 
in Fig. 9 A, while complete TCR complexes are transported 
to the cell surface. In contrast, Fig. 9 B shows predominant 
HRP staining of ER cisternae, nuclear envelope, and transi- 
tional elements and vesicles in 21.2.2 cells. Little or no stain- 
ing of the Golgi cisternae, lysosomes, plasma membrane, 
mitochondria, or cytoplasm is detected. The data are consis- 
tent with our biochemical data suggesting retention of TCR 
chains,  including CD3-e,  in a  pre-Golgi  compartment in 
21.2.2 cells. 
Discussion 
Recent work on a variety of membrane glycoproteins reveals 
the highly selective steps of transport of newly synthesized 
proteins from the rough ER to the Golgi apparatus to the 
plasma membrane (reviewed by Lodish,  1988).  Taken to- 
gether, the data point to the importance of attaining proper 
conformations before proteins can mature from the site of 
synthesis in the ER to the Golgi. While in the ER, most inte- 
gral membrane proteins undergo maturation and modifica- 
tion such as folding, glycosylation, disulfide  bond formation, 
and oligomerization. One well-characterized viral glycopro- 
tein, the influenza hemagglutinin (HA) glycoprotein spike, 
forms a trimer of three identical HA,, polypeptides in the 
ER before the protein is transported to the Golgi (Gething 
et al., 1986; Copeland et al., 1986). Mutants of  the HA poly- 
peptide have been isolated that fail to be transported out of 
the rough ER (Gething et al., 1986). They have been shown 
to be blocked at different stages of the folding process (Geth- 
ing et al., 1986; Doyle et al., 1985).  The wild-type vesicu- 
lar  stomatitis virus  (VSV)  G  glycoprotein also  forms an 
oligomer while it is in the ER (Kreis and Lodish,  1986; 
Doms et al., 1987). Studies of a temperature-sensitive muta- 
tion in the gene encoding this protein (ts045) have shown that 
at the nonpermissive temperature, 39°C, the G protein re- 
mains as a monomer and is retained in the rough ER. At the 
lower permissive temperature, 32°C, oligomerization of the 
G protein occurs and allows normal movement of the protein 
through the Golgi to the cell surface (Kreis and Lodish, 
1986). The human major histocompatibility antigens, HLA-A 
and -B, are oligomeric transmembrane glycoproteins each 
composed of a polymorphic heavy chain associated with a 
water-soluble  nonglycosylated  polypeptide, ~2-microglobulin 
(Ploegh et al., 1979; Owen et al., 1980). Association of the 
132-microglobulin with the heavy chain has been shown to 
be  necessary for  subsequent processing  and intraceUular 
transport of  the heavy chain after synthesis in the ER (Ploegh 
et al., 1979; Owen et al., 1980; Sege et al., 1981). In addi- 
tion, proper folding of the heavy chain itself is required for 
transport of the murine H-2K  b molecule to the cell surface 
(Williams et al., 1988). Finally, retention in the ER has been 
described for both secreted and transmembrane forms of im- 
munoglobulin heavy chains when light chains are not synthe- 
sized (Bole et al.,  1986).  Recently, Sitia et al. (1987) have 
also described retention of IXm heavy chains in transfected 
plasmacytomas that do not synthesize gs. 
We  have  characterized  the  assembly  and  intracellular 
transport of TCR chains in a T cell hybridoma lacking the 
expression of the 13 subunit. In normal 2B4 T cell hybrid- 
omas expressing the complete seven-member TCR on the 
cell surface, five of the chains (a, 13, 8, e, ~/) are synthesized 
in great excess over the amount that eventually assembles 
into mature complexes (Minami et al.,  1987; Lippincott- 
Schwartz et al., 1988; Chen, C., unpublished observations). 
These excess chains that remain as free subunits or as par- 
tiaUy assembled complexes are largely transported to lyso- 
somes  and  are  rapidly  degraded.  Subsequent  studies  on 
a k-deficient T cell hybridoma variant, MA5.8, revealed that 
the ~ chain determines the normal post-Golgi fate of the 
CD3/Ti complex (Sussman et al., 1988a). The k-minus com- 
plexes formed in this cell line are transported normally from 
the ER to the Golgi. However, the majority of these protein 
complexes are then transported to lysosomes and degraded 
while very few complexes reach the cell surface. 
Having seen that k-minus complexes of the TCR surpris- 
ingly exhibit normal transport from the ER to the Golgi, but 
that ER-Golgi transport is highly conformation-dependent 
in several  systems, we wanted to define more precisely the 
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and incubated with 5~A2 followed by peroxidase-conjugated, goat anti-hamster IgG. After reaction with diaminobenzidine hydrochloride/ 
HeO2, cells  were  prepared  for electron microscopy  using a preembedding immunoperoxidase  method  as described  in Materials and 
The Journal  of Cell Biology, Volume 107, 1988  2158 components of the TCR that are necessary for movement out 
of the ER. The present studies used the 21.2.2 13-deficient T 
cell hybridoma line which was generated by repetitive sub- 
cloning of the 2B4 parent cell line (Sussman et al., 1988b). 
This cell line expresses no TCR subunlts on the cell surface 
(Fig. 1) despite the fact that the CD3 chains, 8, e, and y, and 
the ~ chain are all synthesized in normal amounts and are 
partially assembled immediately after synthesis (Fig. 2). The 
partial complexes that are detectable in 21.2.2 only include 
/5-e-y while no associated ¢t or ~ chains are observed, pre- 
sumably because of the lack of 13. Direct immunoprecipita- 
tion of ~ reveals its presence on the surface of 2B4 cells, but 
not on 21.2.2  cells.  We can follow the processing fate of 
CD3-/5 and -% however, because they are glycosylated. They 
are never transported to the Golgi system nor do they ac- 
cumulate in the cis-Golgi stacks as analyzed by digestion of 
carbohydrate chains with Endo H and Endo D (Figs. 3 and 
4, Table I). The Golgi system and the cellular machinery re- 
quired for intracellular transport of proteins are intact and 
functional in 21.2.2 cells, however, because we see normal 
carbohydrate processing of the transferrin receptor in these 
cells (Fig. 4). Taken together, the data suggest that when the 
13 chain of the TCR is not expressed, the resulting partial 
complexes of TCR chains fail to move to the Golgi and are 
retained in a pre-Golgi compartment. We have done some 
preliminary experiments to show that the well-characterized 
lumenal ER protein, BiP (Haas and Wabl, 1983; Bole et al., 
1986; Munro and Pelham, 1986), is not involved in the reten- 
tion of TCR chains in the ER of 21.2.2 cells (Chen, C., un- 
published observations). We were unable to detect an associ- 
ation of BiP with any TCR chains coprecipitated by an anti-e 
antibody. In addition, an anti-BiP antibody (kindly provided 
by Dr.  D.  Bole) did not coprecipitate any detectable TCR 
chains. 
The fate of  the CD3-/5 chain in the pre-Golgi compartment 
of 21.2.2 cells is strikingly different from that of the other 
chains we can examine in 21.2.2 (CD3-y, CD3-e, ~). Only 
the/5 chain is rapidly degraded in these cells (tt/2 =  45-60 
min) while the other chains are extremely stable, showing no 
significant degradation over a 7-h period (Fig. 5). We know 
that the loss of 8 is not due to secretion into the medium or 
to loss of reactivity of the/5 chain with the anti-/5 antibody. 
Interestingly, this pre-Golgi degradative system in T  ceils 
cannot be inhibited by a variety of lysosomal inhibitors, in- 
cluding NI-hC1, MME, chloroquine, leupeptin, and monen- 
sin (Figs.  6  and 7).  The data are analogous to the recent 
findings of pre-Golgi degradation in stable fibroblast trans- 
fectants expressing the TCR-Q and/or -13 chains (Lippincott- 
Schwartz et al.,  1988). We are currently using electron mi- 
croscopy to attempt to localize the site of pre-Golgi/5 degra- 
dation in 21.2.2 cells more precisely. All of our data suggest 
that it is occurring either within or closely related to the ER. 
These data include lack of any Golgi-associated carbohy- 
drate processing of/5 and the steady-state accumulation of  as- 
sociated CD3-e chains in the ER and transitional elements 
of 21.2.2 cells (Fig. 9). Whether or not e, y, and ~ accumu- 
late in the same compartment as the site of/5 degradation re- 
quires further morphological characterization. 
Two possibilities exist for the selective degradation of  TCR 
chains in 21.2.2. First, if the site of degradation is the ER 
itself, we would expect all newly synthesized proteins to pass 
through this  pre-Golgi proteolytic compartment.  Proteins 
that fail to negotiate ER to Golgi transport would be trapped 
within this compartment and thereby subjected to degrada- 
tion.  We would then hypothesize that the  TCR chains  in 
21.2.2  are  intrinsically differentially sensitive to ER pro- 
teases, perhaps due to structural targets for ER degradative 
enzymes that are present only on 6, or to conformational 
differences among the proteins that allow 5 to be more acces- 
sible to proteolytic cleavage. The latter possibility is more 
likely in light of the fact that the CD3-8 and --/chains share 
sequence similarities at both the DNA and protein levels 
(Krissansen et al.,  1986; Gold et al.,  1987). Alternatively, 
proteins that fail to reach the Golgi and are retained stably 
in the ER may be sorted from those that fail to reach the 
Golgi but  are  rapidly degraded.  Such  sorting may be to 
different subregions within the ER or to a distinct, but as yet 
undefined, degradative organelle. In the case of 21.2.2, only 
/5 would undergo selective diversion to such a degradative 
compaa~unent.  For /5  to be selectively degraded by being 
sorted to a degradative organdie, a mechanism must exist for 
dissociating  /5  from  the  already  formed  /5-e-'t  complex. 
Whether such dissociation occurs and, if so, by what mecha- 
nism needs to be addressed. Recent studies in our laboratory 
demonstrate that free/5 is much more rapidly degraded than 
assembled/5 (Lippincott-Schwartz, J., unpublished observa- 
tions). We are currently attempting to determine whether any 
degradation of assembled chains takes place or whether dis- 
sociation is a prerequisite for ER degradation. The results of 
the study on the fate of e when coprecipitated with anti-/5 an- 
tibodies suggest that/5 degradation does not occur at the site 
of synthesis and assembly of receptor chains. However, we 
cannot rule out the possibility that failure to coprecipitate 
with anti-/5 antibodies over time is due to the inability of pre- 
viously synthesized e--/complexes to recombine with newly 
synthesized/5 chains. Whatever the underlying explanation 
for the selective degradation of 8, these studies demonstrate 
that individual proteins when "retained" in the ER can be 
subjected to markedly different fates. This is true even for in- 
dividual components of  an assembled multisubunit complex. 
This selectivity likely provides the cell with an unexpected 
site of specific control in  the processing and  survival of 
newly synthesized proteins. 
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